$EXAS
EXACT SCIENCES CORP Stock $exas

$exas Overview Financials Valuation SEC Filings Company Website

2013 Q2 Form 10-Q Financial Statement

#000110465913059431 Filed on August 02, 2013

Income Statement

Concept	2013 Q2	2012 Q2
Revenue	$1.036M	$1.036M
YoY Change	0.0%	-0.58%
Cost Of Revenue		$0.00
YoY Change		-100.0%
Gross Profit	$1.036M	$1.036M
YoY Change	0.0%	0.0%
Gross Profit Margin	100.0%	100.0%
Selling, General & Admin	$6.930M	$3.724M
YoY Change	86.09%	50.1%
% of Gross Profit	668.92%	359.46%
Research & Development	$6.457M	$12.20M
YoY Change	-47.08%	134.79%
% of Gross Profit	623.26%	1177.8%
Depreciation & Amortization	$300.0K	$200.0K
YoY Change	50.0%
% of Gross Profit	28.96%	19.31%
Operating Expenses	$13.39M	$15.93M
YoY Change	-15.94%	107.42%
Operating Profit	-$12.35M	-$14.89M
YoY Change	-17.05%	124.18%
Interest Expense	$18.00K	$5.000K
YoY Change	260.0%	0.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$12.30M	-$14.80M
YoY Change	-16.89%	124.24%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$12.30M	-$14.80M
YoY Change	-16.89%	124.24%
Net Earnings / Revenue	-1187.26%	-1428.57%
Basic Earnings Per Share
Diluted Earnings Per Share	-$190.1K	-$259.6K
COMMON SHARES
Basic Shares Outstanding	64.10M shares	57.14M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2013 Q2	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$157.7M	$70.90M
YoY Change	122.43%	-15.09%
Cash & Equivalents	$21.52M	$6.026M
Short-Term Investments	$136.2M	$64.80M
Other Short-Term Assets	$1.100M	$2.300M
YoY Change	-52.17%	283.33%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$158.8M	$73.21M
YoY Change	116.93%	-12.95%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.394M	$2.870M
YoY Change	53.1%	105.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$4.394M	$2.870M
YoY Change	53.1%	105.0%
TOTAL ASSETS
Total Short-Term Assets	$158.8M	$73.21M
Total Long-Term Assets	$4.394M	$2.870M
Total Assets	$163.2M	$76.08M
YoY Change	114.52%	-11.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.084M	$800.0K
YoY Change	35.5%	-27.27%
Accrued Expenses	$4.227M	$3.700M
YoY Change	14.24%	105.56%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$300.0K
YoY Change
Total Short-Term Liabilities	$8.019M	$8.639M
YoY Change	-7.18%	21.68%
LONG-TERM LIABILITIES
Long-Term Debt	$1.000M	$1.000M
YoY Change	0.0%	0.0%
Other Long-Term Liabilities	$100.0K	$2.400M
YoY Change	-95.83%	-63.08%
Total Long-Term Liabilities	$1.000M	$3.400M
YoY Change	-70.59%	-54.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.019M	$8.639M
Total Long-Term Liabilities	$1.000M	$3.400M
Total Liabilities	$9.019M	$12.10M
YoY Change	-25.46%	-17.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$297.4M
YoY Change
Common Stock	$451.0M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$153.6M	$64.02M
YoY Change
Total Liabilities & Shareholders Equity	$163.2M	$76.08M
YoY Change	114.52%	-11.02%

Cashflow Statement

Concept	2013 Q2	2012 Q2
OPERATING ACTIVITIES
Net Income	-$12.30M	-$14.80M
YoY Change	-16.89%	124.24%
Depreciation, Depletion And Amortization	$300.0K	$200.0K
YoY Change	50.0%
Cash From Operating Activities	-$9.900M	-$12.30M
YoY Change	-19.51%	108.47%
INVESTING ACTIVITIES
Capital Expenditures	-$1.300M	-$500.0K
YoY Change	160.0%	0.0%
Acquisitions
YoY Change
Other Investing Activities	-$49.00M	$6.300M
YoY Change	-877.78%	-122.83%
Cash From Investing Activities	-$50.30M	$5.800M
YoY Change	-967.24%	-120.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$73.30M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	73.60M	300.0K
YoY Change	24433.33%	50.0%
NET CHANGE
Cash From Operating Activities	-9.900M	-12.30M
Cash From Investing Activities	-50.30M	5.800M
Cash From Financing Activities	73.60M	300.0K
Net Change In Cash	13.40M	-6.200M
YoY Change	-316.13%	-81.66%
FREE CASH FLOW
Cash From Operating Activities	-$9.900M	-$12.30M
Capital Expenditures	-$1.300M	-$500.0K
Free Cash Flow	-$8.600M	-$11.80M
YoY Change	-27.12%	118.52%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q2	exas	Number Of Objectives Of Entitys Investment Strategy NumberOfObjectivesOfEntitysInvestmentStrategy	2	item
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y10M6D
	us-gaap	Share Based Compensation ShareBasedCompensation	2459000	USD
	exas	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0.0276	pure
	exas	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0.0138	pure
CY2013Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	11000000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2013Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	2760000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	2528000	USD
CY2013Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	136194000	USD
CY2013Q2	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	52000	USD
CY2013Q2	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	35000	USD
CY2013Q2	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	136211000	USD
CY2012Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	94698000	USD
CY2012Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	78000	USD
CY2012Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	94776000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7328000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7602000	shares
	exas	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Under Licensing Agreement ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnderLicensingAgreement	80000	shares
	exas	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Under Licensing Agreement ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnderLicensingAgreement	250000	shares
	exas	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Under Consulting Agreement ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnderConsultingAgreement	75000	shares
	exas	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Under Consulting Agreement ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnderConsultingAgreement	75000	shares
CY2013Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	0.01
CY2009Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	75000	shares
CY2012Q2	exas	Vesting Rights Percentage VestingRightsPercentage	0.25	pure
CY2012Q2	exas	Vesting Rights Number Of Annual Installments VestingRightsNumberOfAnnualInstallments	3	item
CY2013Q2	us-gaap	Share Based Compensation ShareBasedCompensation	2800000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3811000	USD
CY2012Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1500000	USD
CY2013Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	70662697	shares
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4394000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Use of Estimates</font></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 20.15pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</font></p> </div>
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	70662697	shares
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Reclassifications</font></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 22.5pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Certain prior year amounts have been reclassified to conform to the current year presentation in the financial statements and accompanying notes to the financial statements.</font></p> </div>
CY2012Q2	us-gaap	Licenses Revenue LicensesRevenue	1036000	USD
	us-gaap	Licenses Revenue LicensesRevenue	2072000	USD
CY2012Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
CY2013Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	58184	USD
CY2012Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	4800	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	71940000	USD
CY2013Q2	exas	Available For Sale Securities Debt Maturities After One Through Two Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue	64271000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	71915000	USD
CY2013Q2	exas	Available For Sale Securities Debt Maturities After One Through Two Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsAmortizedCost	64279000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	136194000	USD
CY2013Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13345000	USD
CY2012Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	94776000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	593000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	108714000	USD
CY2012Q4	exas	Laboratory Equipment Gross LaboratoryEquipmentGross	4051000	USD
CY2012Q4	exas	Office And Computer Equipment Gross OfficeAndComputerEquipmentGross	824000	USD
CY2012Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	283000	USD
CY2012Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	28000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5186000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1781000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3405000	USD
CY2012Q4	us-gaap	Assets Assets	112119000	USD
CY2013Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6749000	USD
CY2013Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q2	us-gaap	Assets Assets	163210000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3652000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3327000	USD
CY2012Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	333000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4143000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11455000	USD
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	8019000	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	USD
CY2012Q4	exas	Interest Payable Noncurrent InterestPayableNoncurrent	63000	USD
CY2012Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	711000	USD
CY2012Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	295000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	639000	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	372123000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	78000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-274245000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	98595000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	112119000	USD
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	163210000	USD
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	153580000	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2013Q2	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63909800	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63909800	shares
CY2013Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1331000	USD
CY2012Q2	us-gaap	Operating Expenses OperatingExpenses	15926000	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-14890000	USD
CY2012Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	59000	USD
CY2012Q2	us-gaap	Interest Expense InterestExpense	5000	USD
CY2012Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14836000	USD
CY2012Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	57037000	shares
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21201000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4538000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25481000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.45
	us-gaap	Operating Expenses OperatingExpenses	27664000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-25592000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	121000	USD
	us-gaap	Interest Expense InterestExpense	10000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-23229000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	1000000	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	56877000	shares
CY2013Q2	us-gaap	Operating Expenses OperatingExpenses	13387000	USD
CY2013Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12314000	USD
	us-gaap	Operating Expenses OperatingExpenses	25320000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-23168000	USD
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12368000	USD
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14804000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25414000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	32000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	67000	USD
	us-gaap	Depreciation Depreciation	646000	USD
	us-gaap	Depreciation Depreciation	417000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-91000	USD
	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	30534	shares
	us-gaap	Deferred Revenue Revenue Recognized DeferredRevenueRevenueRecognized	-2072000	USD
	us-gaap	Deferred Revenue Revenue Recognized DeferredRevenueRevenueRecognized	-2072000	USD
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	152000	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	270000	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	220000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	494000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1313000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2568000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1128000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	10000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	10000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-21959000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-23478000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	71833000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	33764000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	30067000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	26352000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1726000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	729000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-43492000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-8141000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	486000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1864000	USD
	exas	Payments For Capital Lease Obligations PaymentsForCapitalLeaseObligations	164000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	73624000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1864000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	8173000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-29755000	USD
	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss	7000	USD
	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss	67000	USD
	us-gaap	Deferred Compensation Arrangement With Individual Employer Contribution DeferredCompensationArrangementWithIndividualEmployerContribution	354000	USD
	us-gaap	Deferred Compensation Arrangement With Individual Employer Contribution DeferredCompensationArrangementWithIndividualEmployerContribution	274000	USD
	us-gaap	Stock Issued During Period Value Issued For Noncash Considerations StockIssuedDuringPeriodValueIssuedForNoncashConsiderations	194000	USD
	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	32872	shares
	us-gaap	Stock Issued During Period Shares Issued For Noncash Consideration StockIssuedDuringPeriodSharesIssuedForNoncashConsideration	34442	shares
	us-gaap	Stock Issued During Period Shares Issued For Noncash Consideration StockIssuedDuringPeriodSharesIssuedForNoncashConsideration	34336	shares
CY2013Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	USD
CY2013Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3302000	USD
CY2013Q2	exas	Interest Payable Noncurrent InterestPayableNoncurrent	73000	USD
CY2013Q2	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	538000	USD
CY2013Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	28000	USD
CY2013Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2355000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.36
CY2013Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1084000	USD
CY2013Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4227000	USD
CY2013Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	64699000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	64270000	shares
CY2013Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	342000	USD
CY2013Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	55000	USD
CY2013Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2366000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21518000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6026000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35781000	USD
	us-gaap	Licenses Revenue LicensesRevenue	2072000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13983000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6276000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-61000	USD
CY2013Q2	exas	Minimum Contractual Term Of Certain Current Investments Which Can Be Liquidated MinimumContractualTermOfCertainCurrentInvestmentsWhichCanBeLiquidated	P1Y
CY2013Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2012Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2013Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	136211000	USD
CY2013Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1087000	USD
CY2013Q2	us-gaap	Assets Current AssetsCurrent	158816000	USD
CY2013Q2	exas	Laboratory Equipment Gross LaboratoryEquipmentGross	5042000	USD
CY2013Q2	exas	Office And Computer Equipment Gross OfficeAndComputerEquipmentGross	1396000	USD
CY2013Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	283000	USD
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	707000	USD
CY2013Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	450269000	USD
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	17000	USD
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-297413000	USD
CY2013Q2	us-gaap	Licenses Revenue LicensesRevenue	1036000	USD
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6457000	USD
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3628000	USD
CY2013Q2	us-gaap	Interest Expense InterestExpense	18000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-54000	USD
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.19
CY2013Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6325000	shares
CY2013Q2	us-gaap	Share Price SharePrice	12.35
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	73302000	USD
CY2013Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	73300000	USD
	us-gaap	Stock Issued During Period Value Issued For Noncash Considerations StockIssuedDuringPeriodValueIssuedForNoncashConsiderations	261000	USD
CY2013Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	4800000	USD
	exas	Lessee Leasing Arrangements Operating Leases Term Of Contract LesseeLeasingArrangementsOperatingLeasesTermOfContract	P5Y
	exas	Operating Lease Area Under Lease OperatingLeaseAreaUnderLease	29000
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	112000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	676000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	680000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	684000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	689000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	578000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3419000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5061000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-23248000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	117000	USD
	us-gaap	Interest Expense InterestExpense	37000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	USD

Files In Submission

Name	View Source	Status
0001104659-13-059431-index-headers.html	Edgar Link	pending
0001104659-13-059431-index.html	Edgar Link	pending
0001104659-13-059431.txt	Edgar Link	pending
0001104659-13-059431-xbrl.zip	Edgar Link	pending
a13-13606_110q.htm	Edgar Link	pending
a13-13606_1ex10d2.htm	Edgar Link	pending
a13-13606_1ex31d1.htm	Edgar Link	pending
a13-13606_1ex31d2.htm	Edgar Link	pending
a13-13606_1ex32d1.htm	Edgar Link	pending
exas-20130630.xml	Edgar Link	completed
exas-20130630.xsd	Edgar Link	pending
exas-20130630_cal.xml	Edgar Link	unprocessable
exas-20130630_def.xml	Edgar Link	unprocessable
exas-20130630_lab.xml	Edgar Link	unprocessable
exas-20130630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R30.xml	Edgar Link	unprocessable
R31.htm	Edgar Link	pending
R31.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R32.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R33.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EXAS
EXACT SCIENCES CORP Stock $exas

2013 Q2 Form 10-Q Financial Statement

#000110465913059431 Filed on August 02, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS EXACT SCIENCES CORP Stock $exas

2013 Q2 Form 10-Q Financial Statement

#000110465913059431 Filed on August 02, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS
EXACT SCIENCES CORP Stock $exas